Hypopigmentation of the skin
MONDO:0019290A condition caused by a deficiency or a loss of melanin pigmentation in the epidermis, also known as hypomelanosis. Hypopigmentation can be localized or generalized, and may result from genetic defects, trauma, inflammation, or infections.
Also known as: hypopigmentation of the skin, hypopigmentation of the skin (disease), hypomelanoses, hypomelanosis
21 clinical trials for this condition and its sub-types, 2 tagged with Hypopigmentation of the skin itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Hypopigmentation of the skin
-
Syndromic oculocutaneous albinism 0 trials · 12 incl. sub-types
4 sub-types
- Chediak-Higashi syndrome 9 trials
- Hermansky-Pudlak syndrome 4 trials Sub-types →
- Griscelli syndrome 2 trials · 3 incl. sub-types Sub-types →
- Oculocerebral hypopigmentation syndrome, Cross type 0 trials
-
Oculocutaneous albinism 4 trials
9 sub-types
- Oculocutaneous albinism type 1 0 trials · 1 incl. sub-types Sub-types →
- Autosomal dominant oculocutaneous albinism 0 trials
- Oculocutaneous albinism type 2 0 trials
- Oculocutaneous albinism type 3 0 trials
- Oculocutaneous albinism type 4 0 trials
- Oculocutaneous albinism type 5 0 trials
- Oculocutaneous albinism type 6 0 trials
- Oculocutaneous albinism type 7 0 trials
- Oculocutaneous albinism type 8 0 trials
-
Piebaldism 4 trials
-
Tietz syndrome 1 trial
-
Ito hypomelanosis 0 trials
-
Albinism-hearing loss syndrome 0 trials
Most studied deeper sub-types
-
A 5-Day genetic test could slash time to transplant for children with rare immune disease
Diagnosis Not yet recruitingThis trial tests whether a new ultra-rapid genetic test, using third-generation sequencing, can diagnose familial lymphohistiocytosis (FHL) in children within 5 days instead of the usual 6-8 weeks. FHL is a rare, life-threatening genetic condition where the immune system attacks …
Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Diagnosis
Last updated Aug 05, 2026 00:00 UTC
-
Can a common antipsychotic keep cannabis users out of the ER?
Symptom relief Not yet recruitingThis trial tests whether giving patients a prescription for haloperidol to use as needed at home can help control symptoms of cannabinoid hyperemesis syndrome — a condition marked by severe nausea, vomiting, and abdominal pain from heavy cannabis use. The goal is to see if having…
Early phase 1 • Sponsor: University of Illinois at Chicago • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC